← Oncology Approval Tracker

FDA DECISION ·

Methotrexate injection

methotrexate · Accord Healthcare

FDA approvalNew formulationAcute lymphoblastic leukemia, lymphoma and osteosarcoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Intravenous methotrexate for combination regimens in adults and children with acute lymphoblastic leukemia, Burkitt lymphoma or osteosarcoma, and in adults with relapsed or refractory non-Hodgkin lymphoma.

LAMPGEN ANALYSIS

Why it matters

Added a new injectable presentation for established combination chemotherapy uses.

What research teams should watch

Verify the 100 mg/mL concentration, the intravenous route and protocol-specific supportive care.

PRIMARY RECORDS

Sources